Sign up today to unlock access to the downloads available in this area!
Browse by type
Vaccines for a more sustainable future
Sustainability is a challenge that needs to be at the forefront of R&D for vaccines today. The threat is two-fold: overlooking the importance of prioritising sustainable supplies can affect our access to existing vaccines – through depleted sources and unreliable supply chains – and put future vaccines at risk for decades to come. The time it takes for vaccines to be market-ready means that every delay in developing new sustainable ingredients will lead to significant repercussions for the health of subsequent generations. Failing to act now threatens our vaccine access and technologies – effects that will only truly crystallise after the 10 to 20-year-long development timelines.
New & trending
Explore the Virodex™ range for viral inactivation and cell lysis: REACH-compliant, sustainable...
In addition to our standard product Alhydrogel™, Alhydrogel ‘85’ is a distinctly different product,...
Omega 3 long chain poly- unsaturated fatty acids (LCPUFAs) have been linked to eye health in part...
This review aims to highlight the broad range of beneficial effects omega 3 supplementation has on...
Docosahexaenoic acid (DHA) is a fatty acid found in substantial quantities within the brain, higher...
Download our latest whitepaper to learn how cholesterol can enhance stability and efficacy in...
Discover our Crodamol™ range. Croda's fatty acid ester products, produced by the direct...
Super Refined™ excipients for parenteral drug delivery
Pharmaceutical excipients for ophthalmic formulations
A complete vaccines brochure covering our offering across the platforms.
Register to the mailing list to unlock:
- First access to new products, new data and exclusive literature
- Whitepapers and thought provoking content
- Special offers on conference and exhibition passes when available
- Invitations to invite only Croda Pharma events.
View our most recent blogs:
Spotlight on Kritika Bajaj
Highlighting the scientists and teams who are involved in our latest product launch, Virodex™, replacements for Triton™ X-100, we sat down with Kritika Bajaj and asked her about her involvement around...Read more
Croda’s response to Sustainable Markets Initiative for supplier sustainability targets
The recent open letter from the Sustainable Markets Initiative Health Systems Task Force called for Healthcare supply chains to become greener, more efficient and circular and set out a series of...Read more
Sustainability for vaccines: Decarbonisation of one of our key sites
Sustainability is often defined as meeting the needs of those alive today without compromising the ability of future generations to meet their needs. It is a long-term goal that covers three pillars:...Read more
A powerful match - celebrating three years of Croda Pharma and Avanti
Today marks three years since we acquired Avanti Polar Lipids. During the COVID-19 pandemic, it became clear that the combination of Avanti's lipid expertise and our manufacturing scale-up capability...Read more